Institutional investors hold a majority ownership of ACT through the 90.26% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Generic industry. Last, during the quarter ended September 2014, these large investors purchased a net $34.3 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
GLENVIEW CAPITAL MANAGEMENT LLC Bought 1.7 Million shares of Actavis
JENNISON ASSOCIATES LLC Bought 1.6 Million shares of Actavis
VIKING GLOBAL INVESTORS LP Bought 1.3 Million shares of Actavis